openPR Logo
Press release

Investigation for Investors in NYSE: BAX shares over potential Securities Laws Violations by Baxter International Inc.

04-23-2020 10:42 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Baxter International Inc. (NYSE: BAX) shares over potential securities laws violations.

An investigation for investors in Baxter International Inc. (NYSE: BAX) shares over potential securities laws violations.

An investigation was announced over potential securities laws violations by Baxter International Inc. and certain of its directors and officers in connection with certain financial statements.

Investors who purchased shares of Baxter International Inc. (NYSE: BAX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Baxter International Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

The plaintiff alleges that the defendants misrepresented and/or failed to disclose that: (1) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with GAAP and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; (2) Baxter lacked effective internal control over financial reporting; (3) as a result, Baxter's financial statements were misstated and would likely require correction or amendment; (4) due to Baxter's internal investigation, it would not be able to file its quarterly report for the period ending September 30, 2019, with the SEC on a Form 10-Q in a timely manner; and (5) as a result of the foregoing, defendants'

Those who purchased shares of Baxter International Inc. (NYSE: BAX) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Investors in NYSE: BAX shares over potential Securities Laws Violations by Baxter International Inc. here

News-ID: 2022948 • Views: 518

More Releases from Shareholders Foundation

Investigation for Long-Term investors in NASDAQ: KNDI shares over possible Wrong …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Kandi Technologies Group Inc. Investors who are current long term investors in Kandi Technologies Group Inc (NASDAQ: KNDI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: KNDI stocks follows a lawsuit filed
Investigation for Long-Term Investors in shares of Kirby Corporation (NYSE: KEX) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Kirby Corporation. Investors who purchased shares of Kirby Corporation (NYSE: KEX) s have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Kirby Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders. Houston, TX based
Investigation announced for Investors in shares of Builders FirstSource, Inc. (N …
An investigation was announced concerning whether the takeover of Builders FirstSource, Inc. is unfair to NASDAQ: BLDR stockholders. Investors who purchased shares of Builders FirstSource, Inc. (NASDAQ: BLDR) and currently hold any of those NASDAQ: BLDR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Builders FirstSource, Inc. breached their
Investigation for Investors in ANSDAQ: ENDP over possible Wrongdoing at Endo Int …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Endo International plc. Investors who are current long term investors in Endo International plc (NASDAQ: ENDP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: ENDP stocks follows a lawsuit filed against Endo

All 5 Releases


More Releases for Baxter

Global Hemostats Market 2019 - Ethicon, Pfizer, Baxter International Inc
This new report by Eon Market Research, titled “Global Hemostats Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Hemostats industry at a global as well as regional and country level. Key facts analyzed in this report include the Hemostats market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Dysmenorrhea Treatment Market Leading Players Baxter International, Baxter Inter …
Global Dysmenorrhea Treatment Information, By Type Primary, Secondary, By Treatment Non-Steroidal Anti-Inflammatory Drugs, Hormonal, Combined Oral Contraceptive, By End User Hospitals And Clinics, Diagnostic Centers, Pharmaceutical Companies And Others - Forecast To 2023 Dysmenorrhea Treatment Market – Highlights Pain during menstruation is known as dysmenorrhea. Increase in incidence of dysmenorrhea, which is attributed to changing lifestyle, addiction to smoking and alcohol, hormonal changes and physical and mental stress, favor the growth of
Anesthesia Drugs Market 2018; Leading Players Baxter International, Baxter Inter …
Market research future has a half-cooked research report on Global Anesthesia Drugs Market. The global market for Anesthesia Drugs Market is growing continuously and expected to grow at a CAGR of 3.7% from 2015 to 2022 Anesthesia Drugs Market Scenario: Global Anesthesia Drugs Market is growing steadily. Anesthesia is the process of prevention or reduction of the feeling of pain or sensation during surgery or other painful medical procedures. It induced loss
Global Blood Plasma Market 2018 - Baxter, CSL, Grifols, Octapharma, Bayer
Apex Market Reports, recently published a detailed market research study focused on the “Blood Plasma Market” across the global, regional and country level. The report provides 360° analysis of “Blood Plasma Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Blood Plasma on
Global Dialyzer Market 2018 - Baxter, Nipro, Toray, B.Braun
The statistical surveying information incorporated into the Dialyzer report is the aftereffect of significant essential and optional research exercises. The report fragments the worldwide market for Dialyzer based on makers, item compose, applications, and Region. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the worldwide Dialyzer advertise covering key factors, for example, drivers and restrictions affecting the
World Peritoneal Dialysis Solution Market 2017 - Baxter, Fresenius, Nikkiso, Bax …
The report on Global Peritoneal Dialysis Solution Industry 2017 is a professional, in-depth study that includes insights extracted from complex information, which clients can use for their business advantage. A large volume of precise, reliable market data has been distilled into clear and actionable insight for clients so that they can formulate their plans or make crucial business decisions with precision. Get Free Report Sample @ http://www.fiormarkets.com/report-detail/40468/request-sample The report begins with an